sulpirid tardiv dyskinesia abnorm involuntari movement tardiv dyskinesia dopamin antagonist drug phenothiazin butyrophenon increas parkinsonian sign sulpirid benzamid deriv select antagonist receptor benefici effect patient patient improv reduct abnorm movement low dose necessari dose sulpirid mg signific side effect trial addit month treatment 